Benefit assessment of dietary salt reduction: While the doctors study, should more people die?

Journal of Hypertension

Volumn 29, Issue 5, 2011, Pages 829-831

  Strazzullo, Pasquale ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST;

BLOOD PRESSURE REGULATION; CLINICAL RESEARCH; COST BENEFIT ANALYSIS; EDITORIAL; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MORTALITY; OUTCOME ASSESSMENT; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK BENEFIT ANALYSIS; SALT INTAKE;

EID: 79954605844     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283459568     Document Type: Editorial

References (36)

1. Matyas E, Jeitler K, Horvath K, Semlitsch T, Hemkensc LG, Pignitter N, Siebenhofer A. Benefit assessment of salt reduction in patients with hypertension: systematic overview. J Hypertens 2011; 29:821-828.
2. World Health Organization. Reducing salt intake in populations: report of a WHO forum and technical meeting. Geneva: WHO; 2007. pp. 1-60.
3. US Department of Agriculture and US Department of Health and Human Services. Dietary guidelines for Americans, 2010. 7th ed. Washington, DC: US Government Printing Office; December 2010.
4. Strazzullo P, D'Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009; 339:b4567.
5. Laatikainen T, Pietinen P, Valsta L, Sundvall J, Reinivuo H, Tuomilehto J. Sodium in the Finnish diet: 20-year trends in urinary sodium excretion among the adult population. Eur J Clin Nutr 2006; 60:965-970. (Pubitemid 44161017)
6. Sasaki N. The salt factor in apoplexy and hypertension: epidemiological studies in Japan. In: Yamori Y, editor. Prophylactic approach to hypertensive diseases. New York: Raven Press; 1979. pp. 467-474.
7. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 h urinary sodium and potassium excretion. BMJ 1988; 297:319-328.
8. Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens 2003; 17:623-630. (Pubitemid 37265100)
9. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 1988; 78:951-956.
10. Du Cailar G, Ribstein J, Daures JP, Mimran A. Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol 1992; 263:H177-H181.
11. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36-37 years. Focus on lifestyle and salt intake. Circulation 1994; 89:1041-1050. (Pubitemid 24076528)
12. Ferrara LA, de Simone G, Pasanisi F, Mancini M. Left ventricular mass reduction during salt depletion in arterial hypertension. Hypertension 1984; 6:755-759. (Pubitemid 15210519)
13. Jula AM, Karanko HM. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation 1994; 89:1023-1031. (Pubitemid 24076526)
14. Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91:698-706.
15. Du Cailar G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002; 15:222-229. (Pubitemid 34226186)
16. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004; 256:324-330. (Pubitemid 39304344)
17. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart study. Circulation 2005; 112:969-975. (Pubitemid 41170264)
18. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension 2005; 46:308-312. (Pubitemid 41099162)
19. Houlihan CA, Allen TJ, Baxter AL, Panangiotopoulos S, Casley DJ, Cooper ME, et al. A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 2002; 25:663-671. (Pubitemid 41071184)
20. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346:77-84. (Pubitemid 34438897)
21. Seals DR, Tanaka H, Clevenger CM, Monahan KD, Reiling MJ, Hiatt WR, et al. Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol 2001; 38:506-513. (Pubitemid 32721781)
22. Hu J, Jiang X, Li N, Yu X, Perkovic V, Chen B, et al. Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: a randomized controlled trial. Hypertens Res 2009; 32:282-288.
23. He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, MacGregor GA. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 2009; 54:482-488.
24. Graudal NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA 1998; 279:1383-1391.
25. He FJ, MacGregorGA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16:761-770. (Pubitemid 36007929)
26. Beckmann SL, Os I, Kjeldsen SE, Eide IK, Westheim AS, Hjermann I. Effect of dietary counselling on blood pressure and arterial plasma catecholamines in primary hypertension. Am J Hypertens 1995; 8:704-711.
27. McCarron DA, Drueke TB, Stricker EM. Science trumps politics: urinary sodium data challenge US dietary sodium guideline. Am J Clin Nutr 2010; 92:1005-1006.
28. Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE, Vaughan ED Jr. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med 1972; 52:633-652.
29. Brunner HR, Chang P, Wallach R, Sealey JE, Laragh JH. Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension. J Clin Invest 1972; 51:58-67.
30. Fava C, Montagnana M, Rosberg L, Burri P, Almgren P, Jö nsson A, et al. Subjects heterozygous for genetic loss of function of the thiazidesensitive cotransporter have reduced blood pressure. Hum Mol Genet 2008; 17:413-418.
31. Labarthe D, Wang G. Cost-effectiveness of salt reduction interventions. In: Creating an enabling environment for population based salt reduction strategies. WHO-FSA joint meeting; London; July 2010.
32. Palar K, Sturm R. Potential societal savings from reduced sodium consumption in the US adult population. Am J Health Promot 2009; 24:49-57.
33. Dall TM, Fulgoni VL 3rd, Zhang Y, Reimers KJ, Packard PT, Astwood JD. Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet. Am J Health Promot 2009; 23:412-422.
34. Rubinstein A, Colantonio L, Bardach A, Caporale J, Mart́ SG, Kopitowski K, et al. Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventive interventions to reduce this burden in Argentina. BMC Public Health 2010; 10:627.
35. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362:590-599.
36. Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease. A cost-effectiveness analysis. Ann Intern Med 2010; 152:481-487.